Zomedica Pharmaceuticals Corp (CVE:ZOM) shares reached a new 52-week low during trading on Wednesday . The stock traded as low as C$1.08 and last traded at C$1.08, with a volume of 2000 shares changing hands. The stock had previously closed at C$1.31.

The stock has a market cap of $132.47 million and a P/E ratio of -5.56.

TRADEMARK VIOLATION NOTICE: This report was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another publication, it was stolen and reposted in violation of U.S. and international trademark and copyright legislation. The legal version of this report can be read at https://www.thecerbatgem.com/2019/03/15/zomedica-pharmaceuticals-zom-sets-new-12-month-low-at-1-08.html.

About Zomedica Pharmaceuticals (CVE:ZOM)

Zomedica Pharmaceuticals Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. The company's lead drug product candidate is ZM-012, a tablet formulation of metronidazole targeting the treatment of acute diarrhea in dogs.

See Also: What type of investment options does a Roth IRA provide?

Receive News & Ratings for Zomedica Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zomedica Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.